Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study - Institut de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition Accéder directement au contenu
Article Dans Une Revue European Radiology Année : 2023

Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study

Lucie Cassagnes
  • Fonction : Auteur
Jeremy Charriot
  • Fonction : Auteur
Philippe Khafagy
  • Fonction : Auteur
Richard Chocron
  • Fonction : Auteur
Ian Leonard Lorant
  • Fonction : Auteur
Loic Metairy
  • Fonction : Auteur
Lea Ruez-Lantuejoul
  • Fonction : Auteur
Sébastien Beaune
  • Fonction : Auteur
Pierre Hausfater
  • Fonction : Auteur
Jennifer Truchot
  • Fonction : Auteur
Antoine Khalil
  • Fonction : Auteur
Andrea Penaloza
  • Fonction : Auteur
Thibaut Affole
  • Fonction : Auteur
Pierre-Yves Brillet
Catherine Roy
  • Fonction : Auteur
Julien Pucheux
  • Fonction : Auteur
Jordan Zbili
  • Fonction : Auteur
Olivier Sanchez
  • Fonction : Auteur

Résumé

Objectives: The objective was to define a safe strategy to exclude pulmonary embolism (PE) in COVID-19 outpatients, without performing CT pulmonary angiogram (CTPA). Methods: COVID-19 outpatients from 15 university hospitals who underwent a CTPA were retrospectively evaluated. D-Dimers, variables of the revised Geneva and Wells scores, as well as laboratory findings and clinical characteristics related to COVID-19 pneumonia, were collected. CTPA reports were reviewed for the presence of PE and the extent of COVID-19 disease. PE rule-out strategies were based solely on D-Dimer tests using different thresholds, the revised Geneva and Wells scores, and a COVID-19 PE prediction model built on our dataset were compared. The area under the receiver operating characteristics curve (AUC), failure rate, and efficiency were calculated. Results: In total, 1369 patients were included of whom 124 were PE positive (9.1%). Failure rate and efficiency of D-Dimer > 500 μg/l were 0.9% (95%CI, 0.2-4.8%) and 10.1% (8.5-11.9%), respectively, increasing to 1.0% (0.2-5.3%) and 16.4% (14.4-18.7%), respectively, for an age- adjusted D-Dimer level. D-dimer > 1000 μg/l led to an unacceptable failure rate to 8.1% (4.4-14.5%). The best performances of the revised Geneva and Wells scores were obtained using the age-adjusted D-Dimer level. They had the same failure rate of 1.0% (0.2-5.3%) for efficiency of 16.8% (14.7-19.1%), and 16.9% (14.8-19.2%) respectively. The developed COVID-19 PE prediction model had an AUC of 0.609 (0.594-0.623) with an efficiency of 20.5% (18.4-22.8%) when its failure was set to 0.8%. Conclusions: The strategy to safely exclude PE in COVID-19 outpatients should not differ from that used in non-COVID-19 patients. The added value of the COVID-19 PE prediction model is minor. Key points: • D-dimer level remains the most important predictor of pulmonary embolism in COVID-19 patients. • The AUCs of the revised Geneva and Wells scores using an age-adjusted D-dimer threshold were 0.587 (95%CI, 0.572 to 0.603) and 0.588 (95%CI, 0.572 to 0.603). • The AUC of COVID-19-specific strategy to rule out pulmonary embolism ranged from 0.513 (95%CI: 0.503 to 0.522) to 0.609 (95%CI: 0.594 to 0.623).
Fichier principal
Vignette du fichier
2023 Chassagnon et al Strategies to safely.pdf (507.67 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04249768 , version 1 (26-02-2023)
hal-04249768 , version 2 (05-02-2024)

Identifiants

Citer

Guillaume Chassagnon, Mostafa El Hajjam, Samia Boussouar, Marie-Pierre Revel, Ralph Khoury, et al.. Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study. European Radiology, 2023, 33 (8), pp.5540-5548. ⟨10.1007/s00330-023-09475-6⟩. ⟨hal-04249768v2⟩
136 Consultations
39 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More